Companies Dominating the Hematopoietic Stem Cells Transplantation Landscape
- Lonza Group Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Escape Therapeutics, Inc.
- Regen BioPharma, Inc.
- ThermoGenesis Holdings, Inc.
- CSG-BIO Company, Inc. (CellSave)
- CBR Systems, Inc.
- Pluristem Inc.
- Global Cord Blood Corporation
- ViaCord, LLC
- Cynata Therapeutics Limited
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Hematopoietic Stem Cells Transplantation Market in 2025 is assessed at USD 3.29 billion.
The global market size surpassed USD 3.05 billion in 2024 and is projected to witness a CAGR of over 9.7%, crossing USD 10.16 billion revenue by 2037.
North America is forecast to see USD 4.06 billion by 2037, due to strong key player presence and mergers in stem cell therapies.
The major players in the market include Escape Therapeutics, Inc., Regen BioPharma, Inc., ThermoGenesis Holdings, Inc., CSG-BIO Company, Inc. (CellSave), CBR Systems, Inc., Pluristem Inc., Global Cord Blood Corporation, ViaCord, LLC, Cynata Therapeutics Limited, and others.
